Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4/A Registration of securities issued in business combination transactions
- 4.18 EX-4.18
- 4.19 EX-4.19
- 4.20 EX-4.20
- 4.21 EX-4.21
- 5.1 EX-5.1
- 5.2 EX-5.2
- 5.3 EX-5.3
- 5.4 EX-5.4
- 5.5 EX-5.5
- 5.6 EX-5.6
- 5.7 EX-5.7
- 5.8 EX-5.8
- 5.9 EX-5.9
- 12.1 EX-12.1
- 12.2 EX-12.2
- 23.1 EX-23.1
- 23.2 EX-23.2
- 23.3 EX-23.3
- 23.4 EX-23.4
- 23.5 EX-23.5
- 25.1 EX-25.1
- 99.1 EX-99.1
- 99.2 EX-99.2
- 99.3 EX-99.3
- 99.4 EX-99.4
First Check Ecom similar filings
- 8 Apr 13 Registration of securities issued in business combination transactions
- 26 Nov 10 Registration of securities issued in business combination transactions
- 26 Mar 10 Registration of securities issued in business combination transactions (amended)
- 12 Feb 10 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 23.3
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated May 19, 2009, with respect to the combined statements of assets acquired and liabilities assumed of the Second Territory Business of ACON Laboratories, Inc., AZURE Institute, Inc., Oakville Hong Kong Co., Ltd, and ACON Biotech (Hangzhou) Co., Ltd as of December 31, 2008 and 2007, and the related statements of revenue and direct expenses for each of the years ending December 31, 2008 and 2007, contained in the Registration Statement and Prospectus. We consent to the use of the aforementioned report in the Registration Statement and Prospectus, and to the use of our name as it appears under the caption “Experts.”
/s/ Grant Thornton Zhonghua
Shanghai, China
March 26, 2010
March 26, 2010